
Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) – Erste Group Bank upped their FY2027 EPS estimates for Intuitive Surgical in a report issued on Thursday, June 25th. Erste Group Bank analyst H. Engel now expects that the medical equipment provider will post earnings of $9.94 per share for the year, up from their previous forecast of $9.90. The consensus estimate for Intuitive Surgical’s current full-year earnings is $8.57 per share.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.08 by $0.42. The business had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The firm’s revenue for the quarter was up 23.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.81 EPS.
Check Out Our Latest Stock Report on Intuitive Surgical
Intuitive Surgical Trading Up 0.3%
ISRG stock opened at $405.97 on Tuesday. The firm’s 50-day moving average price is $431.63 and its two-hundred day moving average price is $482.96. Intuitive Surgical has a 12-month low of $396.68 and a 12-month high of $603.88. The stock has a market capitalization of $143.78 billion, a price-to-earnings ratio of 49.21, a PEG ratio of 3.29 and a beta of 1.46.
Insiders Place Their Bets
In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction that occurred on Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total transaction of $169,656.00. Following the transaction, the executive vice president owned 5,720 shares in the company, valued at approximately $2,426,080.80. This represents a 6.54% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the transaction, the senior vice president directly owned 6,463 shares of the company’s stock, valued at $2,718,014.65. This represents a 46.53% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 7,169 shares of company stock worth $3,059,135 over the last three months. Company insiders own 0.60% of the company’s stock.
Institutional Investors Weigh In On Intuitive Surgical
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Holos Integrated Wealth LLC purchased a new position in Intuitive Surgical during the fourth quarter valued at $25,000. Newbridge Financial Services Group Inc. grew its position in shares of Intuitive Surgical by 300.0% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 33 shares during the period. Olistico Wealth LLC bought a new position in shares of Intuitive Surgical in the 4th quarter worth about $28,000. Caitlin John LLC bought a new position in shares of Intuitive Surgical in the 3rd quarter worth about $30,000. Finally, Main Street Group LTD purchased a new position in Intuitive Surgical during the 1st quarter valued at about $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.
About Intuitive Surgical
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Further Reading
- Five stocks we like better than Intuitive Surgical
- Rezolve AI Stock Has a Short-Squeeze Setup, But Execution Comes First
- SpaceX Achieves Escape Velocity With Nasdaq Fast-Track
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
